Grillon A - Search Results

1

A Population Pharmacokinetic Analysis of Continuous Infusion of Cloxacillin during Staphylococcus aureus Bone and Joint Infections.

Courjon J, Garzaro M, Roger PM, Ruimy R, Lavrut T, Chelli M, Raynier JL, Chirio D, Demonchy E, Cabane L, Jehl F, Trojani C, Grillon A, Goutelle S. Courjon J, et al. Among authors: grillon a. Antimicrob Agents Chemother. 2020 Nov 17;64(12):e01562-20. doi: 10.1128/AAC.01562-20. Print 2020 Nov 17. Antimicrob Agents Chemother. 2020. PMID: 32988822 Free PMC article. Clinical Trial.

2

Comparative Activity of Ciprofloxacin, Levofloxacin and Moxifloxacin against Klebsiella pneumoniae, Pseudomonas aeruginosa and Stenotrophomonas maltophilia Assessed by Minimum Inhibitory Concentrations and Time-Kill Studies.

Grillon A, Schramm F, Kleinberg M, Jehl F. Grillon A, et al. PLoS One. 2016 Jun 3;11(6):e0156690. doi: 10.1371/journal.pone.0156690. eCollection 2016. PLoS One. 2016. PMID: 27257956 Free PMC article.

3

Inventory of Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae in France as Assessed by a Multicenter Study.

Robin F, Beyrouthy R, Bonacorsi S, Aissa N, Bret L, Brieu N, Cattoir V, Chapuis A, Chardon H, Degand N, Doucet-Populaire F, Dubois V, Fortineau N, Grillon A, Lanotte P, Leyssene D, Patry I, Podglajen I, Recule C, Ros A, Colomb-Cotinat M, Ponties V, Ploy MC, Bonnet R. Robin F, et al. Among authors: grillon a. Antimicrob Agents Chemother. 2017 Feb 23;61(3):e01911-16. doi: 10.1128/AAC.01911-16. Print 2017 Mar. Antimicrob Agents Chemother. 2017. PMID: 27956424 Free PMC article.

4

Breakpoint to MIC quotient: A parameter to rapidly evaluate the in vitro bactericidal activity of β-lactams on Enterobacteriaceae.

Grillon A, Chabaud A, Zambardi G, Caniaux I, Jehl F. Grillon A, et al. Int J Antimicrob Agents. 2019 May;53(5):674-677. doi: 10.1016/j.ijantimicag.2019.01.013. Epub 2019 Feb 1. Int J Antimicrob Agents. 2019. PMID: 30716447

5

Bone penetration of daptomycin in diabetic patients with bacterial foot infections.

Grillon A, Argemi X, Gaudias J, Ronde-Ousteau C, Boeri C, Jenny JY, Hansmann Y, Lefebvre N, Jehl F. Grillon A, et al. Int J Infect Dis. 2019 Aug;85:127-131. doi: 10.1016/j.ijid.2019.05.011. Epub 2019 May 13. Int J Infect Dis. 2019. PMID: 31096056 Free article. Clinical Trial.

6

Low prevalence of tissue detection of cefepime and daptomycin used as empirical treatment during revision for periprosthetic joint infections: results of a prospective multicenter study.

Robineau O, Talagrand-Reboulh E, Brunschweiler B, Jehl F, Beltrand E, Rousseau F, Blondiaux N, Grillon A, Joseph C, Lambotte P, Boyer P, Senneville E; from behalf of the G4 Bone and Joint infection study group. Robineau O, et al. Among authors: grillon a. Eur J Clin Microbiol Infect Dis. 2021 Nov;40(11):2285-2294. doi: 10.1007/s10096-021-04277-4. Epub 2021 May 20. Eur J Clin Microbiol Infect Dis. 2021. PMID: 34014434

7

Daptomycin Physiology-Based Pharmacokinetic Modeling to Predict Drug Exposure and Pharmacodynamics in Skin and Bone Tissues.

Garreau R, Montange D, Grillon A, Jehl F, Ferry T, Bourguignon L, Goutelle S. Garreau R, et al. Among authors: grillon a. Clin Pharmacokinet. 2022 Oct;61(10):1443-1456. doi: 10.1007/s40262-022-01168-5. Epub 2022 Aug 16. Clin Pharmacokinet. 2022. PMID: 35972685

8

Bone marrow necrosis induced by massive Staphylococcus aureus infiltration.

Jandeaux LM, Eischen A, Grillon A, Demiselle J. Jandeaux LM, et al. Among authors: grillon a. Intensive Care Med. 2022 Jun;48(6):746-747. doi: 10.1007/s00134-022-06619-y. Epub 2022 Jan 20. Intensive Care Med. 2022. PMID: 35050385 No abstract available.

9

[Antimicrobial resistance patterns in pediatric febrile urinary tract infection and empirical antibacterial therapy. An epidemiological study in secondary and tertiary care centers in the north-east of France in 2019-2020].

Arabska M, Girardin ML, Long L, Grillon A, Zaloszyc A. Arabska M, et al. Among authors: grillon a. Nephrol Ther. 2022 Apr;18(2):129-135. doi: 10.1016/j.nephro.2021.11.003. Epub 2022 Mar 5. Nephrol Ther. 2022. PMID: 35260346 French.

10

Fosfomycin, from susceptibility to resistance: Impact of the new guidelines on breakpoints.

Farfour E, Degand N, Riverain E, Fihman V, Le Brun C, Péan de Ponfilly G, Muggeo A, Jousset A, Piau C, Lesprit P; GMC study group. Farfour E, et al. Med Mal Infect. 2020 Oct;50(7):611-616. doi: 10.1016/j.medmal.2020.07.003. Epub 2020 Jul 15. Med Mal Infect. 2020. PMID: 32679342

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

45 results

Search Page